Nature Communications (Nov 2023)

ZHX2 emerges as a negative regulator of mitochondrial oxidative phosphorylation during acute liver injury

  • Yankun Zhang,
  • Yuchen Fan,
  • Huili Hu,
  • Xiaohui Zhang,
  • Zehua Wang,
  • Zhuanchang Wu,
  • Liyuan Wang,
  • Xiangguo Yu,
  • Xiaojia Song,
  • Peng Xiang,
  • Xiaodong Zhang,
  • Tixiao Wang,
  • Siyu Tan,
  • Chunyang Li,
  • Lifen Gao,
  • Xiaohong Liang,
  • Shuijie Li,
  • Nailin Li,
  • Xuetian Yue,
  • Chunhong Ma

DOI
https://doi.org/10.1038/s41467-023-43439-0
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 18

Abstract

Read online

Abstract Mitochondria dysfunction contributes to acute liver injuries, and mitochondrial regulators, such as PGC-1α and MCJ, affect liver regeneration. Therefore, identification of mitochondrial modulators may pave the way for developing therapeutic strategies. Here, ZHX2 is identified as a mitochondrial regulator during acute liver injury. ZHX2 both transcriptionally inhibits expression of several mitochondrial electron transport chain genes and decreases PGC-1α stability, leading to reduction of mitochondrial mass and OXPHOS. Loss of Zhx2 promotes liver recovery by increasing mitochondrial OXPHOS in mice with partial hepatectomy or CCl4-induced liver injury, and inhibition of PGC-1α or electron transport chain abolishes these effects. Notably, ZHX2 expression is higher in liver tissues from patients with drug-induced liver injury and is negatively correlated with mitochondrial mass marker TOM20. Delivery of shRNA targeting Zhx2 effectively protects mice from CCl4-induced liver injury. Together, our data clarify ZHX2 as a negative regulator of mitochondrial OXPHOS and a potential target for developing strategies for improving liver recovery after acute injuries.